ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

QUCY vs INO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Quantum Cyber N.V. (NASDAQ) VS. Inovio Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: QUCY 3 — INO 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QUCY VS. INO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC QUCY INO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 72.60% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -13.84% — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -39.90% -65.00% +25.10 QUCY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 QUCY /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.3 27.1 +4.27 QUCY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $79.4M $79.8M -$432.7K INO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR QUCY REV INO REV QUCY GROSS % INO GROSS % QUCY FCF INO FCF
FY 2025 $537.1K $65.3K 72.6% — -$11.0M -$88.9M
FY 2024 $894.0K $217.8K 64.3% — -$17.4M -$104.6M
FY 2023 — $832.0K — — — -$124.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QUCY // BETA —
INO // BETA —